256 related articles for article (PubMed ID: 36359910)
1. The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia.
Grimaldi B; Kohan-Ghadr HR; Drewlo S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359910
[TBL] [Abstract][Full Text] [Related]
2. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
Liu L; Wang R; Xu R; Chu Y; Gu W
Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta.
Grimaldi B; Kohan-Ghadr HR; Halari CD; Nandi P; Kingdom JC; Drewlo S
Hypertension; 2023 Nov; 80(11):2386-2396. PubMed ID: 37702083
[TBL] [Abstract][Full Text] [Related]
4. Maternal vitamin D deficiency reduces docosahexaenoic acid, placental growth factor and peroxisome proliferator activated receptor gamma levels in the pup brain in a rat model of preeclampsia.
Nema J; Randhir K; Wadhwani N; Sundrani D; Joshi S
Prostaglandins Leukot Essent Fatty Acids; 2021 Dec; 175():102364. PubMed ID: 34768025
[TBL] [Abstract][Full Text] [Related]
5. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
7. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
8. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.
Wang Y; Adair CD; Weeks JW; Lewis DF; Alexander JS
J Soc Gynecol Investig; 1999; 6(3):136-41. PubMed ID: 10376269
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia.
Matsuyama T; Tomimatsu T; Mimura K; Yagi K; Kawanishi Y; Kakigano A; Nakamura H; Endo M; Kimura T
J Reprod Immunol; 2021 Jun; 145():103322. PubMed ID: 33887508
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
[TBL] [Abstract][Full Text] [Related]
11. Induction of the PPARγ (Peroxisome Proliferator-Activated Receptor γ)-GCM1 (Glial Cell Missing 1) Syncytialization Axis Reduces sFLT1 (Soluble fms-Like Tyrosine Kinase 1) in the Preeclamptic Placenta.
Armistead B; Kadam L; Siegwald E; McCarthy FP; Kingdom JC; Kohan-Ghadr HR; Drewlo S
Hypertension; 2021 Jul; 78(1):230-240. PubMed ID: 34024123
[TBL] [Abstract][Full Text] [Related]
12. ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.
Liu L; Zhuang X; Jiang M; Guan F; Fu Q; Lin J
Cell Death Dis; 2017 Sep; 8(9):e3054. PubMed ID: 28933788
[TBL] [Abstract][Full Text] [Related]
13. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells.
Cawyer C; Afroze SH; Drever N; Allen S; Jones R; Zawieja DC; Kuehl T; Uddin MN
Hypertens Pregnancy; 2016 May; 35(2):159-69. PubMed ID: 26930265
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
19. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
20. Placental growth factor is negatively regulated by epidermal growth factor receptor (EGFR) signaling.
Whigham CA; Hastie R; Hannan NJ; Brownfoot F; Pritchard N; Cannon P; Nguyen TV; Kandel M; Masci J; Tong S; Kaitu'u-Lino TJ
Placenta; 2021 Oct; 114():22-28. PubMed ID: 34418751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
